Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 109
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Endocrinol Invest ; 46(1): 59-65, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-35945394

RESUMEN

OBJECTIVE: Myxedema crisis (MC) is a rare condition. There is a dearth of data regarding the predictors of mortality in MC. Predictive scores for mortality specific to the clinical and biochemical profile of MC are still lacking. DESIGN AND METHODS: All consecutive patients presenting with MC from September 2006 to December 2020 comprised the new cohort. Patients managed between January 1999 and August 2006 comprised the old cohort. Both cohorts were compared for the determination of secular trends. Combined analysis of both the cohorts was done for clinico-demographic profile and predictors of mortality. Myxedema score (MS) and qSOFA (Quick Sequential Organ Failure Assessment) score were evaluated in all the patients. RESULTS: A total of forty-one patients (new cohort; n = 18 and old cohort; n = 23) were enrolled into the study. There was a female predominance (80.5%). Nearly half (51.2%) of the patients were newly diagnosed with hypothyroidism on admission. Overall mortality was 60.9%. On comparative analysis among survivors and non-survivors, female gender (OR 20.4, p value 0.018), need for mechanical ventilation (OR16.4, p value 0.009), in-hospital hypotension (OR 9.1, p value 0.020), and high qSOFA score (OR 7.1, p value 0.023) predicted mortality. MS of > 90 had significantly higher mortality (OR-11.8, p value - 0.026) while MS of > 110 had 100% mortality. There was no change in secular trends over last 20 years. There was no difference in outcome of patients receiving oral or IV levothyroxine. CONCLUSION: Myxedema crisis is associated with high mortality despite improvement in health care services. The current study is first to elucidate the role of the MS in predicting mortality in patients with MC.


Asunto(s)
Hipotiroidismo , Mixedema , Sepsis , Humanos , Femenino , Masculino , Mixedema/diagnóstico , Mixedema/complicaciones , Coma/complicaciones , Coma/diagnóstico , Hipotiroidismo/complicaciones , Tiroxina , Mortalidad Hospitalaria , Sepsis/complicaciones , Estudios Retrospectivos
2.
Phys Rev Lett ; 126(7): 076602, 2021 Feb 19.
Artículo en Inglés | MEDLINE | ID: mdl-33666464

RESUMEN

As exemplified by the growing interest in the quantum anomalous Hall effect, the research on topology as an organizing principle of quantum matter is greatly enriched from the interplay with magnetism. In this vein, we present a combined electrical and thermoelectrical transport study on the magnetic Weyl semimetal EuCd_{2}As_{2}. Unconventional contribution to the anomalous Hall and anomalous Nernst effects were observed both above and below the magnetic transition temperature of EuCd_{2}As_{2}, indicating the existence of significant Berry curvature. EuCd_{2}As_{2} represents a rare case in which this unconventional transverse transport emerges both above and below the magnetic transition temperature in the same material. The transport properties evolve with temperature and field in the antiferromagnetic phase in a different manner than in the paramagnetic phase, suggesting different mechanisms to their origin. Our results indicate EuCd_{2}As_{2} is a fertile playground for investigating the interplay between magnetism and topology, and potentially a plethora of topologically nontrivial phases rooted in this interplay.

3.
Diabet Med ; 35(11): 1613-1616, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-29888479

RESUMEN

BACKGROUND: Sodium-glucose co-transporter-2 inhibitors are novel antidiabetes drugs that act via inhibition of renal glucose reabsorption. This action causes osmotic diuresis, reduces intravascular volume and is associated with various adverse effects. In the present paper, we describe the first report on the unmasking of underlying polycythemia vera by canagliflozin in a person with Type 2 diabetes mellitus, which was temporally related to the use of the drug. CASE REPORT: A 51-year-old obese man with Type 2 diabetes was prescribed canagliflozin 100 mg for control of his glycaemia. He presented 6 months later with asymptomatic elevation of his haemogram measurements (haemoglobin: 16.9 g/dl; haematocrit: 55%; red cell number: 8.1 million/mm3 ; total leukocytes: 23010/mm3 ; platelet count: 9.7 *106 /mm3 ). He had no history of smoking, exposure to high altitude or other drugs. Subsequent investigations revealed myeloproliferative neoplasm (polycythemia vera) on trephine biopsy of bone marrow, normal erythropoietin level and JAK2V617F positivity. Because of the possibility that the underlying condition had been unmasked by canagliflozin, the latter was stopped. This led to a remarkable improvement in the man's haematological profile, with no other significant intervention. The man subsequently restarted the drug of his own accord, causing his haematological profile to worsen again and thereby posing a challenge in monitoring of both polycythemia vera as well as diabetes mellitus. CONCLUSION: This report brings to light unmasking of a new adverse effect of sodium-glucose co-transporter-2 inhibitors in clinical practice caused by volume loss, apart from hypotension and falls.


Asunto(s)
Canagliflozina/uso terapéutico , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Policitemia Vera/inducido químicamente , Policitemia Vera/diagnóstico , Diagnóstico Diferencial , Progresión de la Enfermedad , Humanos , Masculino , Persona de Mediana Edad , Obesidad/complicaciones , Obesidad/tratamiento farmacológico , Policitemia Vera/complicaciones , Policitemia Vera/patología
5.
Ann Oncol ; 26(1): 198-205, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25361984

RESUMEN

BACKGROUND: Human papillomavirus (HPV) has emerged as a causative agent and positive prognostic factor for oropharyngeal (OP) head and neck squamous cell cancer (HNSCC). This prompts inquiry into whether therapy improvements or increasing incidence of HPV drives the apparent improvements in HNSCC outcomes observed in non-randomized clinical trials. PATIENTS AND METHODS: We reviewed all locoregionally advanced HNSCC patients treated with chemotherapy and radiation in prospective institutional trials at a single institution. Patients were divided into three groups (1, 2, 3) according to treatment time period (1993-1998, 1999-2003, 2004-2010, respectively). We reasoned that if a favorable trend was observed over time in OP but not non-OP patients, HPV status may be confounding treatment effects, whereas this would be unlikely if both subgroups improved over time. RESULTS: Four hundred and twenty-two patients were identified with OP (55.7%) and non-OP (44.3%) HNSCC. Five-year OP overall survival (OS) improved from 42.3% (group 1) to 72.5% (group 2), and 78.4% (group 3), adjusted P = 0.0084. Non-OP 5-year OS was 51.0% (group 1), 58.8% (group 2), and 66.3% (group 3), adjusted P = 0.51. Five-year recurrence-free survival (RFS) improved for OP groups from 42.3% to 68.4% to 75.8% (adjusted P = 0.017). Non-OP 5-year RFS was 42.9%, 53.6%, and 61.7% for sequential groups (adjusted P = 0.30). Five-year OP distant failure-free survival (DFFS) improved from 42.3% to 71.1% to 77.8% (adjusted P = 0.011). Five-year non-OP DFFS was 46.9%, 57.1%, and 66.0% for sequential groups (adjusted P = 0.38). CONCLUSIONS: Over the past two decades, OP HNSCC outcomes improved significantly, while non-OP outcomes only trended toward improvement. Although our patients are not stratified by HPV status, improving OP outcomes are likely at least partly due to the increasing HPV incidence. These data further justify trial stratification by HPV status, investigations of novel approaches for carcinogen-related HNSCC, and current de-intensification for HPV-related HNSCC.


Asunto(s)
Carcinoma de Células Escamosas , Neoplasias de Cabeza y Cuello , Neoplasias Orofaríngeas , Infecciones por Papillomavirus/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/diagnóstico por imagen , Carcinoma de Células Escamosas/tratamiento farmacológico , Carcinoma de Células Escamosas/virología , Femenino , Neoplasias de Cabeza y Cuello/diagnóstico por imagen , Neoplasias de Cabeza y Cuello/tratamiento farmacológico , Neoplasias de Cabeza y Cuello/virología , Humanos , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/mortalidad , Neoplasias Orofaríngeas/diagnóstico por imagen , Neoplasias Orofaríngeas/tratamiento farmacológico , Neoplasias Orofaríngeas/virología , Papillomaviridae , Estudios Prospectivos , Radiografía , Fumar , Carcinoma de Células Escamosas de Cabeza y Cuello , Resultado del Tratamiento
6.
Lupus ; 24(9): 998-1005, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25926055

RESUMEN

Childhood-onset systemic lupus erythematosus (cSLE) is a multisystem autoimmune disease characterized by immune dysregulation affecting patients less than 18 years old. One-fifth of SLE cases are diagnosed during childhood. cSLE presents differently from adults and has a more severe and aggressive course. We describe the clinical and antibody profiles in our cSLE Singapore cohort. All cSLE patients who satisfied the 1997 American College of Rheumatology diagnostic criteria were captured in our lupus registry from January 2009 to January 2014. Data including demographic, cumulative clinical, serologic data, and damage indices were collected. Adjusted mean SLEDAI-2K (AMS) was used to summarize disease activity over multiple visits. Cluster analysis using non-hierarchical K-means procedure was performed on eight selected antibodies. The 64 patients (female:male ratio 5:1; Chinese 45.3%, Malay 28.1%, Indian 9.4%, and other races 17.2%) had a mean onset age of 11.5 years (range 2.1-16.7) and mean age at diagnosis was 11.9 years (range 2.6-18.0). Our study demonstrated differences in clinical manifestations for which hematologic involvement was the most common manifestation with less renal disease and uncommon neurologic manifestation as compared to other cSLE cohorts reported in our region. Antibody clusters were identified in our cohort but their clinical association/discrimination and outcome prediction required further validation study. Outcomes of our cohort in regard to disease activity after therapy and organ damages were comparable if not better to other cSLE cohorts elsewhere. Steroid-related damage, including symptomatic multifocal avascular necrosis and cataract, were not uncommon locally. Infection remains the major cause of death for the continent. Nevertheless, the five year survival rate of our cohort (98.4%) was high.


Asunto(s)
Anticuerpos Antinucleares/sangre , Autoanticuerpos/sangre , Lupus Eritematoso Sistémico/inmunología , Adolescente , Edad de Inicio , Niño , Preescolar , Análisis por Conglomerados , Estudios de Cohortes , Femenino , Humanos , Lupus Eritematoso Sistémico/sangre , Lupus Eritematoso Sistémico/epidemiología , Lupus Eritematoso Sistémico/patología , Masculino , Evaluación de Resultado en la Atención de Salud , Fenotipo , Singapur/epidemiología
7.
J Clin Pediatr Dent ; 38(3): 235-9, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25095318

RESUMEN

UNLABELLED: Oxidative stress plays a pivotal role in the pathogenesis of neurological disorders. Saliva may constitute a first line of defence, against free radical-modified oxidative stress. The objective of the present study was to evaluate Total Antioxidant Capacity (TAC), levels of Nitric Oxide (NO), and Sialic Acid (SA) in saliva of cerebral palsied children. STUDY DESIGN: Thirty four non-institutionalized children in the age group of 7-12 years having cerebral palsy formed the study group. The control group consisted of thirty three normal, healthy children. The W.H.O. criteria was used for diagnosis and recording of dental caries. Oral hygiene status was assessed using the Simplified Oral Hygiene Index OHI-S. Estimation of Total Antioxidant Capacity, levels of Nitric Oxide and Sialic Acid in saliva was done. Data obtained was subjected to statistical analysis. RESULTS: Children with CP had higher deft scores than that of normal children. Oral hygiene of children with CP was significantly poorer than that of normal children. Total Antioxidant Capacity of saliva was significantly higher in normal children than cerebral palsied children. Levels of Sialic Acid in saliva were significantly higher in cerebral palsy children. CONCLUSIONS: In children with CP, TAC of saliva showed an inverse relation with dental caries.


Asunto(s)
Antioxidantes/análisis , Parálisis Cerebral/metabolismo , Estado de Salud , Salud Bucal , Saliva/química , Estudios de Casos y Controles , Niño , Índice CPO , Caries Dental/diagnóstico , Femenino , Humanos , Masculino , Ácido N-Acetilneuramínico/análisis , Óxido Nítrico/análisis , Índice de Higiene Oral , Estrés Oxidativo/fisiología , Espectrofotometría/métodos
8.
Parasitol Res ; 112(6): 2353-9, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23525692

RESUMEN

Diethylcarbamazine (DEC) interferes with arachidonic acid metabolism for the clearance of microfilariae in Wuchereria bancrofti infected individuals. In this study, we have quantified the plasma concentrations of prostaglandin E2 (PGE2) and 6-keto-PGF1α, the end products of arachidonic acid metabolic pathway in microfilaraemics (DEC treated and untreated), and normal healthy individuals at pre- and 3,9,12,36, and 72 h of post-DEC treatment. We have also determined the microfilariae counts at pre and post day 2 (36 h) and day 3 (72 h) of DEC treatment by membrane filtration technique. Significant reduction in PGE2 and 6-keto-PGF1α concentrations was found at 12 h of DEC treatment. Rapid reduction in microfilarial counts was observed at 36 h of post-DEC treatment. Higher levels of prostaglandins were found at pre-treatment hours in microfilaraemics compared to normal healthy individuals (P < 0.05). Our findings indicate that DEC inhibits prostaglandins for the clearance of microfilariae, and increased levels of prostaglandins in microfilaraemics may be contributed by the parasite or host upon stimulation.


Asunto(s)
6-Cetoprostaglandina F1 alfa/sangre , Dietilcarbamazina/administración & dosificación , Dinoprostona/sangre , Filariasis Linfática/tratamiento farmacológico , Filaricidas/administración & dosificación , Wuchereria bancrofti/aislamiento & purificación , Animales , Filariasis Linfática/parasitología , Humanos , Parasitemia
9.
J Commun Dis ; 45(1-2): 17-23, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-25141550

RESUMEN

Lymphoedema of extremities is a major clinical manifestation of lymphatic filariasis. Recurrent episodes of acute dermato-lymphangioadenitis (ADLA) in these patients lead to progression of the clinical condition. Studies have documented the effectiveness of regular limb hygiene in reduction in frequency and duration of ADLA. However, no data is available on the effectiveness of limb hygiene alone on reduction of lymphoedema volume and locomotor function of the affected extremities. A total of 93 consecutive patients visiting VCRC Filaria Clinic formed a cohort for the study. The limb hygiene kit was supplied monthly free of cost to the patients. Assessments of oedema volume, frequency and duration of ADLA and quantitative assessment of locomotor function were carried out at baseline and after 12 months of intervention. All the 93 patients completed the follow-up. A total of 82 (88%) patients practiced limb hygiene regularly. The practice was higher among patients with higher grades of lymphoedema. The mean frequency of ADLA reduced from pre-intervention level of 2.4 to 0.8 during 12-month period of intervention in grade I cases, from 3.4 to 1.2 in grade II and from 4.8 to 1.8 in grade III cases. The mean duration (in days) for each ADLA episode was reduced from 4 at the rpe-intervention level and 2.5 during the 12-months intervention period. Though 'limb hygiene' practiced in domiciliary settings is feasible. Regular practices resulted in reduction of frequency and duration of ADLA attacks. However, reduction in oedema volume or improvement the locomotor function was not observed during 12 month period.


Asunto(s)
Filariasis Linfática/terapia , Linfedema/terapia , Actividad Motora/fisiología , Adulto , Filariasis Linfática/complicaciones , Humanos , Higiene , India/epidemiología , Linfedema/etiología , Persona de Mediana Edad
10.
Biomed Microdevices ; 14(5): 955-64, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22767244

RESUMEN

This paper reports the design and fabrication of electrode microtraps for single cell trapping and impedance measurement. In this work, the microtrap electrodes of parallel and elliptical geometry have been fabricated by electroplating of gold electrodes of optimum thickness. This has enabled the formation of electrode traps without requiring any precision alignment between separate insulating traps like PDMS and the bottom gold electrodes. Further the improved uniformity of the electric field between the trapping electrodes as observed from COVENTORWARE simulation significantly reduces the effect of cell position inside the microwell on the electrical measurement unlike previous reports. This makes it possible to directly extract the equivalent cell parameters from the electrical measurement without introducing any correction factor corresponding to cell position. We have performed impedance spectroscopy with both the microwell electrode structures with single HeLa cell at two different positions of trapping. It has been observed that there is almost no change in the extracted values of cell resistance and capacitance for different positions within parallel electrodes and there is only 0.7 % and 0.85 % change in cell resistance and capacitance for the two positions within elliptical electrodes. Thus these microwell electrode structures can be used as an improved and a more convenient platform for single cell electrical characterization.


Asunto(s)
Técnicas Analíticas Microfluídicas/instrumentación , Microfluídica/instrumentación , Microfluídica/métodos , Análisis de la Célula Individual/instrumentación , Simulación por Computador , Espectroscopía Dieléctrica , Capacidad Eléctrica , Impedancia Eléctrica , Electricidad , Diseño de Equipo , Células HeLa , Humanos , Microelectrodos , Técnicas Analíticas Microfluídicas/métodos , Modelos Teóricos , Análisis de la Célula Individual/métodos , Programas Informáticos
11.
Artículo en Inglés | MEDLINE | ID: mdl-22290349

RESUMEN

This study was focussed on identifying a cost-effective method for delimitation, monitoring and evaluation in bancroftian filariasis. Finger prick blood samples were collected between 20.00 and 23.00 hours for the detection of microfilariae (mf) from the available population in a village which was endemic for lymphatic filariasis. Simultaneously, from each individual, four spots of 25-µl blood samples were collected on Whatman number 3 filter paper and air dried. Dried filter paper spots were pooled in quantities of 1, 5, 10, 15, 20 and 25 on unknown and simulated mf and antigen prevalence. Pooled samples were assayed for circulating filarial antigen (CFA) using TropBIO Og4C3 ELISA kits. The community mf and CFA rates were 3.4% and 25.9%, respectively. The pool sizes of 20 and 25 showed CFA positivity in all the above categories tested. The results of the pooled blood spot samples suggest that, in areas with mf and CFA prevalence rates between 1 and 10%, pools of 20 or 25 could be considered as the ideal pool size for the detection of filarial infection in the community. CFA prevalence at the level of 5-6% following desirable rounds of mass drug administration (MDA) indicates that the community mf prevalence is likely to be at the 1% level.

12.
J Eur Acad Dermatol Venereol ; 26(8): 1031-4, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21797929

RESUMEN

AIM: The aim of this study was to know the correlation of patients' 3 months recall on acute dermato-lymphangio-adenitis (ADLA) with anti-streptolysin O (ASO) serology and its application as a tool to know the burden of ADLA in the community. METHODS: Fifty-nine lymphoedema (LE) patients and 27 age matched controls were clinically assessed for LE and the occurrence of ADLA during the previous 3 months was obtained by recall. After obtaining the informed consent, 2 mL of venous blood sample was collected and ASO was quantified in Olympus AU400 auto-analyzer. RESULTS: When the results were computed as two groups, controls and LE patients with no reported ADLA and LE patients with reported ADLA (by 3 months recall), the ASO positivity and ASO titre was significantly higher in the later group (P < 0.05). When the results were computed as three groups, controls with no reported ADLA, LE patients with no reported ADLA and LE patients with reported ADLA, the ASO titre was significantly higher in LE patients reported ADLA (P < 0.05). CONCLUSION: As ASO was measured in post-infection phase, we relied on the ASO titre for making conclusion. Patients' 3 months recall on ADLA correlates with the ASO titre and therefore, it could be considered as a tool to measure the burden of ADLA in the community. Multicentre community-based studies are needed to ascertain the findings.


Asunto(s)
Filariasis/complicaciones , Linfedema/complicaciones , Infecciones Estreptocócicas/sangre , Enfermedad Aguda , Estudios de Casos y Controles , Humanos
13.
ScientificWorldJournal ; 2012: 372618, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22654597

RESUMEN

Lymphatic filariasis is a vector borne parasitic disease causing long term disability. The Global Programme to Eliminate Lymphatic Filariasis aims to achieve its objective through two strategies; Mass Drug Administration (MDA) to interrupt transmission and Morbidity Management (MM) to manage disability for those already affected. MDA is going on in full swing in endemic areas; but MM is lagging behind. An exploratory study was conducted in Pondicherry through focus group discussions to find out whether there are delivery issues if any, in the MM programme and get suggestions from end users. The study results show that MM has not received the same attention as MDA and there are shortcomings in the delivery mechanism of the programme. The importance of these findings are discussed and suggestions given for improving the programme.


Asunto(s)
Manejo de la Enfermedad , Filariasis Linfática , Femenino , Humanos , India , Masculino , Morbilidad
14.
Malays Orthop J ; 15(2): 89-95, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-34429827

RESUMEN

INTRODUCTION: The aim of this study is to assess the outcomes of ala carte posteromedial release in children over two years of age who were not responding to the Ponseti method of treatment of idiopathic clubfoot. MATERIAL AND METHODS: A retrospective observational study from September 2013 to August 2015 was conducted at a tertiary level medical teaching institution. The clubfeet were classified according to the Harold and Walker classification. Radiographic parameters assessed were the talocalcaneal angle (AP, lateral), talus-first metatarsal angle (AP, lateral) and calcaneal-fifth metatarsal angle. The scar and the functional score, according to Laaveg and Ponseti, were evaluated as outcome measures at the final follow-up. RESULTS: Twenty-four children with a mean age of 43.7 ± 24.7 months were enrolled in the study. There was a total of 36 clubfeet: 21 (65.6%) with a poor functional outcome; 12 (37.4%) with excellent to good scar in both horizontal and vertical components. There was a statistical significance between the pre-operative and post-operative radiological parameters (p<0.05). None of the patients presented with any limitation of activities of daily living despite the poor functional outcome in many of the children. There was no significant association between the qualities of scar (horizontal, vertical) and the functional outcome with age at presentation, pre-operative Harold and Walker classification and pre-operative radiographic angles. CONCLUSION: Surgical intervention in terms of ala carte posteromedial soft tissue release could not produce a good outcome over four years in CTEV. The threshold for surgery in CTEV should be high, given the poor results.

15.
Ann Trop Med Parasitol ; 104(5): 421-6, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20819310

RESUMEN

Between November 2006 and November 2009, the stigmata and discrimination experienced by 201 cases of lymphatic filariasis (LF) living in three areas of the southern Indian state of Tamil Nadu (the Pondicherry urban agglomeration and two, endemic, rural villages in Villupuram district) were investigated in interviews. The narratives of nine of the interviewees are reported here in detail, to bring to light the various domains of life in which LF cases are stigmatized and discriminated against. Lymphatic filariasis can, and often does, adversely affect each case's livelihood, marital prospects, and social and marital life and can also diminish the marital prospects of a case's children. The deformity caused by the disease and the incapacitation resulting from the often-frequent attacks of adenolymphangitis appeared to be the main reasons for the stigmatization and discrimination. Although morbidity control is one of the 'twin pillars' of the Global Programme for Elimination of Filariasis, the stigmata and discrimination associated with such morbidity also need to be addressed.


Asunto(s)
Filariasis Linfática/psicología , Relaciones Interpersonales , Prejuicio , Adolescente , Adulto , Empleo , Femenino , Humanos , India , Masculino , Matrimonio , Persona de Mediana Edad , Investigación Cualitativa , Encuestas y Cuestionarios , Adulto Joven
16.
Natl Med J India ; 23(2): 72-6, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20925201

RESUMEN

BACKGROUND: Lymphatic filariasis is a major vector-borne parasitic disease. The global programme to eliminate lymphatic filariasis was launched in 1997 and currently over 570 million people are covered under it in 48 countries. Mass annual single-dose drug administration of diethylcarbamazine (DEC), co-administrated with albendazole for 5-6 years and mass distribution of diethylcarbamazine-fortified salt are the two strategies for elimination of filariasis. METHODS: Asymptomatic volunteers residing in Puducherry, India were screened for microfilaria (mf) by examining nocturnal thick blood smears. Those testing positive were randomly assigned to receive a single dose of DEC (6 mg/kg body weight) or albendazole 400 mg or both. Participants were hospitalized for 5 days. Membrane filtration count was used to assess microfilaraemia and ELISA (Og4C3) assay to measure circulating filarial antigens (CFA). Measurements were done before treatment and at 1, 2 and 3 years post-treatment. Viability of the adult worms was assessed by looking for the filarial dance sign (FDS) using ultrasound examination of the scrotum in men with hydrocele. RESULTS: Fifty-four microfilaraemic Individuals were studied. The mf prevalence started decreasing only by day 180 posttreatment in the DEC group but much earlier in the other two groups (day 30 in the albendazole and day 90 in the DEC with albendazole group). The decrease in mfwas marginal (17.6%, 26.3% and 27.8%, respectively) by the end of year 1 posttreatment, but significant (96.7%, 78.6% and 93.3%, respectively) by the end of year 2 post-treatment (p < 0.05). By the end of year 3, the level decreased to 80% in the DEC, 90% in the albendazole and to 100% in the DEC and albendazole groups. However, the mf intensity decreased significantly (by 39%; p < 0.05) by day 7 post-treatment in both the DEC and DEC with albendazole groups, but only by day 30 in the albendazole group. In all the drug groups, the prevalence as well as intensity of CFA returned to pretreatment levels by the end of year 3 post-treatment. CONCLUSION: Annual single-dose administration of all the 3 drug regimens significantly reduced antigenaemia levels. There were no significant differences in the efficacy and overall pattern of CFA clearance between the 3 drug regimens.


Asunto(s)
Albendazol/uso terapéutico , Antihelmínticos/uso terapéutico , Antígenos Helmínticos/sangre , Portador Sano/tratamiento farmacológico , Dietilcarbamazina/uso terapéutico , Filariasis/tratamiento farmacológico , Microfilarias/efectos de los fármacos , Wuchereria bancrofti/efectos de los fármacos , Adolescente , Adulto , Albendazol/administración & dosificación , Animales , Niño , Dietilcarbamazina/administración & dosificación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Parasitemia/tratamiento farmacológico
17.
J Vector Borne Dis ; 46(1): 26-35, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19326705

RESUMEN

BACKGROUND & OBJECTIVES: During 2006, chikungunya emerged as a major ever known epidemic in India. Disability adjusted life years (DALY) is an appropriate summary measure of population health to express epidemiological burden of diseases. We estimated the burden due to suspected chikungunya using DALYs for the first time and compared between the states and also with the burden due to other vector-borne diseases in India. The economic burden was also assessed in terms of productivity loss. METHODS: Data on the reported cases of fever/suspected cases of chikungunya from different states during 2006 in India were used. Years lived with disability (YLD) were calculated for non-fatal cases to estimate DALY. Since the disability weight for chikungunya is not available, the weights available for rheumatic arthritis, comparable to the disease outcome of chikungunya were used for the estimation. The burden was estimated for both acute and chronic cases. It is considered that about 11.5% of cases were reported to have extended morbidity with persisting arthralgia. For acute disease, the average duration of illness was considered to be nine days and for chronic cases it was six months on an average. The productivity loss due to income foregone by the working class was calculated using minimum official wage. RESULTS: National burden of chikungunya was estimated to be 25,588 DALYs lost during 2006 epidemic, with an overall burden of 45.26 DALYs per million. It varied from 0.01 to 265.62 per million in different states. Karnataka alone contributed as high as 55% of the national burden. Persistent arthralgia was found to impose heavy burden, accounting for 69% of the total DALYs. The productivity loss in terms of income foregone was estimated to be a minimum of Rs. 391 million. INTERPRETATION & CONCLUSION: The chikungunya epidemic in the year 2006 imposed heavy epidemiological burden and productivity loss to the community. The burden of chikungunya in terms of DALY was estimated for the first time. In view of re-emergence and spread of this infection in recent times it is warranted for derivation of disability weight for different health states of chikungunya to facilitate realistic estimates of DALYs. Quality epidemiological data from surveillance system to monitor vector-borne and zoonotic diseases would pave way for more realistic estimates of burden. The productivity loss in-terms of income foregone could be minimal as the estimation was made by using the minimum wage fixed by the government although the actual loss is expected to be higher.


Asunto(s)
Infecciones por Alphavirus/epidemiología , Virus Chikungunya/aislamiento & purificación , Brotes de Enfermedades , Femenino , Humanos , India/epidemiología , Masculino , Años de Vida Ajustados por Calidad de Vida
18.
Heliyon ; 5(8): e02250, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31440597

RESUMEN

The study was carried out to determine the natural regeneration of four species of mangroves along with estimation of physico-chemical characteristics of sediment and water from seven sites of mangroves in the southern Gulf of Kachchh. Spatial variation of different parameters of water and sediment investigated were: water-pH (7.87-8.04); Salinity (37.07-39.42 ppt); Nitrate (1.21-2.71 ppm); Nitrite (0.03-0.08 ppm); Phosphate (0.39-0.95 ppm) and sediment-pH (7.39-7.61); Bulk density (0.36-0.54 g/cc); Particle density (1.19-1.68 g/cc); Organic carbon (0.77-1.05%); and Organic matter (1.06-1.71%). The density (recruit/sq. m) of natural recruitment of four mangrove species was in order of Avicennia marina > Ceriops tagal > Aegiceras corniculatum > Rhizophora mucronata. Cluster analysis grouped seven sites in three major clusters i.e. Group A (Poshitra & Khijadiya - 91% similarity); Group B (Dedeka-Mundeka, Kalubhar & Pirotan- 94% similarity) and Group C (Sikka & Jodiya- 93% similarity) whereas Non-metric multidimensional scaling showed formation of two groups (Coastal and Islands) depending on the environmental conditions and mangrove natural regeneration. Principal component analysis showed the number of parameters such as salinity, texture and organic carbon which affects the natural regeneration of mangrove species in the study area.

20.
J Commun Dis ; 40(1): 13-9, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19127664

RESUMEN

Disability prevention in cases with lymphatic filarial disease has been a research priority in view of the current programme on global elimination of lymphatic filariasis. This is also important for estimation of disease burden, impact evaluation, developing strategy for morbidity management and rehabilitation for lymphoedema patients in the endemic countries. In this communication, we are presenting the results of quantification of functional limitations of lower extremities with lymphoedema caused due to bancroftian filariasis by objective assessment of movement of joints and power of muscles in the affected legs. A total of 81 consecutive lymphoedema patients attending a filariasis clinic in Pondicherry urban locality were recruited for the study. Assessment for restriction of movement of joints and loss of power of muscles was carried out as in Manual for doctors to evaluate permanent physical impairment, prescribed by an expert group of WHO and Ministry of Health, Govt. of India on evaluation for permanent disability. Of the cases assessed, 40% in grade-I, 55% in grade-II, 77.3% in grade-III and 94.7% in grade-IV lymphoedema cases had functional limitations either in joint movements or power of muscles or both. The effective loss of locomotor/function (combined loss of joint movement and power of muscles in %) increased with stage of lymphoedema (grade-I-4.3+7.4, grade-II-7.0+8.4, grade-III-15.4+14.8 and grade IV- 33.2+22.8). The degree of loss varied significantly between the grades (P< 0.0001). The methodology used in this study can be adapted to evaluate the impact of the morbidity management component of strategy for Elimination of Lymphatic Flariasis (ELF) programme. This study will also enable researchers for fine-tuning the method for estimating disease burden and, to develop and evaluate strategies for morbidity management/rehabilitation of filarial lymphoedema patients.


Asunto(s)
Evaluación de la Discapacidad , Filariasis Linfática/fisiopatología , Limitación de la Movilidad , Wuchereria bancrofti , Actividades Cotidianas , Adulto , Anciano , Animales , Estudios de Cohortes , Femenino , Humanos , Masculino , Persona de Mediana Edad , Rango del Movimiento Articular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA